Fig. 1.
Hyperleukocytosis developed in newly diagnosed patients during As2O3 treatment. * represents that patient died on day 15 after As2O3 treatment. Arrow indicates the time when chemotherapy was administered. Case 11 is not shown here because the patient died on day 1 of As2O3 treatment.
